- Home
- PSNY vs RLAY Comparison
PSNY vs RLAY Comparison
Compare PSNY & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNY | RLAY |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PSNY | RLAY |
|---|---|---|
| Price | $16.68 | $10.55 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $15.00 | $14.50 |
| AVG Volume (30 Days) | 204.5K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $49.59 | N/A |
| Revenue Next Year | $31.71 | $396.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $0.50 | $1.78 |
| 52 Week High | $23.28 | $11.43 |
Technical Indicators
Market Signals| Indicator | PSNY | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 64.10 |
| Support Level | $15.84 | $7.22 |
| Resistance Level | $23.02 | $11.43 |
| Average True Range (ATR) | 1.60 | 0.72 |
| MACD | -0.33 | 0.08 |
| Stochastic Oscillator | 19.51 | 69.42 |
Price Performance
Historical ComparisonAbout PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).